IOL Chemicals and Pharmaceuticals Ltd's product approved by CDE of NMPA, China

IOL Chemicals and Pharmaceuticals Limited's product "Metformin Hydrochloride" has been approved by Center for Drug Evaluation (CDE) of National Medical Products Administration (NMPA), China.

This will enable the Company to export Metformin Hydrochloride in China Market. Metformin Hydrochloride is an antidiabetic drug which is used to manage the high blood sugar levels in diabetes patients.

Shares of IOL Chemicals and Pharmaceuticals Limited was last trading in BSE at Rs. 404.10 as compared to the previous close of Rs. 411.45. The total number of shares traded during the day was 14416 in over 1067 trades.

The stock hit an intraday high of Rs. 411.00 and intraday low of 402.25. The net turnover during the day was Rs. 5860307.00.

Source : Equity Bulls

Keywords

IOLChemicalsandPharmaceuticals INE485C01011 MetforminHydrochloride Approval CDE NMPA China